Nautilus Bio

IPO

Reveal hidden biology

San Diego, United States · Founded 2016 · $113.6M raised

Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$113.6M
Last Round
$76.0M Series BMay 2020
Rounds
2

About

Nautilus Biotechnology (Nasdaq: NAUT) is a proteomics company, founded in 2016, that has built the Nautilus Voyager Platform using a technique called Iterative Mapping to achieve single-molecule quantification of proteins and proteoforms across the human proteome. Its technology targets pharmaceutical and academic researchers pursuing drug discovery, biomarker discovery, and exploratory biology, and the company runs research collaborations with academic partners such as Weill Cornell Medicine-Qatar and the Michael J. Fox Foundation.

Summary

Nautilus Bio is a Biotech company based in San Diego, United States, founded in 2016. It has raised $113.6M in total across 2 rounds, most recently a $76.0M Series B round in May 2020. Investors include Perceptive Advisors, Vulcan Capital and Andreessen Horowitz.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SPAC MergerSPAC MergerFeb 2021
$350.0M

Sign up to see all 3 rounds

Series A through SPAC Merger — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nautilus Bio on Indexed.vc
<a href="https://indexed.vc/companies/nautilus-bio"><img src="https://indexed.vc/api/badge/company/nautilus-bio" alt="Nautilus Bio on Indexed.vc" width="260" height="76" /></a>